Advances in medical imaging for the diagnosis and management of common genitourinary cancers

Mohammad H. Bagheri; Mark A. Ahlman; Liza Lindenberg; Baris Turkbey; Jeffrey Lin; Ali Cahid Civelek; Ashkan A. Malayeri; Piyush K. Agarwal; Peter L. Choyke; Les R. Folio; Andrea B. Apolo

doi:10.1016/j.urolonc.2017.04.014

Advances in medical imaging for the diagnosis and management of common genitourinary cancers

Mohammad H. Bagheri, Mark A. Ahlman, Liza Lindenberg, Baris Turkbey, Jeffrey Lin, Ali Cahid Civelek, Ashkan A. Malayeri, Piyush K. Agarwal, Peter L. Choyke, Les R. Folio, Andrea B. Apolo

Research output: Contribution to journal › Review article › peer-review

43 Scopus citations

Abstract

Medical imaging of the 3 most common genitourinary (GU) cancers—prostate adenocarcinoma, renal cell carcinoma, and urothelial carcinoma of the bladder—has evolved significantly during the last decades. The most commonly used imaging modalities for the diagnosis, staging, and follow-up of GU cancers are computed tomography, magnetic resonance imaging (MRI), and positron emission tomography (PET). Multiplanar multidetector computed tomography and multiparametric MRI with diffusion-weighted imaging are the main imaging modalities for renal cell carcinoma and urothelial carcinoma, and although multiparametric MRI is rapidly becoming the main imaging tool in the evaluation of prostate adenocarcinoma, biopsy is still required for diagnosis. Functional and molecular imaging using 18-fluorodeoxyglucose-PET and sodium fluoride-PET are essential for the diagnosis, and especially follow-up, of metastatic GU tumors. This review provides an overview of the latest advances in the imaging of these 3 major GU cancers.

Original language	English (US)
Pages (from-to)	473-491
Number of pages	19
Journal	Urologic Oncology: Seminars and Original Investigations
Volume	35
Issue number	7
DOIs	https://doi.org/10.1016/j.urolonc.2017.04.014
State	Published - Jul 2017
Externally published	Yes

Keywords

Bladder urothelial carcinoma
CT
MRI
PET
Prostate adenocarcinoma
Renal cell carcinoma

ASJC Scopus subject areas

Oncology
Urology

UN SDGs

This output contributes to the following UN Sustainable Development Goals (SDGs)

Access to Document

10.1016/j.urolonc.2017.04.014

Cite this

Bagheri, M. H., Ahlman, M. A., Lindenberg, L., Turkbey, B., Lin, J., Cahid Civelek, A., Malayeri, A. A., Agarwal, P. K., Choyke, P. L., Folio, L. R., & Apolo, A. B. (2017). Advances in medical imaging for the diagnosis and management of common genitourinary cancers. Urologic Oncology: Seminars and Original Investigations, 35(7), 473-491. https://doi.org/10.1016/j.urolonc.2017.04.014

Bagheri, MH, Ahlman, MA, Lindenberg, L, Turkbey, B, Lin, J, Cahid Civelek, A, Malayeri, AA, Agarwal, PK, Choyke, PL, Folio, LR & Apolo, AB 2017, 'Advances in medical imaging for the diagnosis and management of common genitourinary cancers', Urologic Oncology: Seminars and Original Investigations, vol. 35, no. 7, pp. 473-491. https://doi.org/10.1016/j.urolonc.2017.04.014

@article{9f6246bb646e471ba0abfab572a48478,

title = "Advances in medical imaging for the diagnosis and management of common genitourinary cancers",

abstract = "Medical imaging of the 3 most common genitourinary (GU) cancers—prostate adenocarcinoma, renal cell carcinoma, and urothelial carcinoma of the bladder—has evolved significantly during the last decades. The most commonly used imaging modalities for the diagnosis, staging, and follow-up of GU cancers are computed tomography, magnetic resonance imaging (MRI), and positron emission tomography (PET). Multiplanar multidetector computed tomography and multiparametric MRI with diffusion-weighted imaging are the main imaging modalities for renal cell carcinoma and urothelial carcinoma, and although multiparametric MRI is rapidly becoming the main imaging tool in the evaluation of prostate adenocarcinoma, biopsy is still required for diagnosis. Functional and molecular imaging using 18-fluorodeoxyglucose-PET and sodium fluoride-PET are essential for the diagnosis, and especially follow-up, of metastatic GU tumors. This review provides an overview of the latest advances in the imaging of these 3 major GU cancers.",

keywords = "Bladder urothelial carcinoma, CT, MRI, PET, Prostate adenocarcinoma, Renal cell carcinoma",

author = "Bagheri, {Mohammad H.} and Ahlman, {Mark A.} and Liza Lindenberg and Baris Turkbey and Jeffrey Lin and {Cahid Civelek}, Ali and Malayeri, {Ashkan A.} and Agarwal, {Piyush K.} and Choyke, {Peter L.} and Folio, {Les R.} and Apolo, {Andrea B.}",

note = "Publisher Copyright: {\textcopyright} 2017",

year = "2017",

month = jul,

doi = "10.1016/j.urolonc.2017.04.014",

language = "English (US)",

volume = "35",

pages = "473--491",

journal = "Urologic Oncology: Seminars and Original Investigations",

issn = "1078-1439",

publisher = "Elsevier Inc.",

number = "7",

}

TY - JOUR

T1 - Advances in medical imaging for the diagnosis and management of common genitourinary cancers

AU - Bagheri, Mohammad H.

AU - Ahlman, Mark A.

AU - Lindenberg, Liza

AU - Turkbey, Baris

AU - Lin, Jeffrey

AU - Cahid Civelek, Ali

AU - Malayeri, Ashkan A.

AU - Agarwal, Piyush K.

AU - Choyke, Peter L.

AU - Folio, Les R.

AU - Apolo, Andrea B.

PY - 2017/7

Y1 - 2017/7

N2 - Medical imaging of the 3 most common genitourinary (GU) cancers—prostate adenocarcinoma, renal cell carcinoma, and urothelial carcinoma of the bladder—has evolved significantly during the last decades. The most commonly used imaging modalities for the diagnosis, staging, and follow-up of GU cancers are computed tomography, magnetic resonance imaging (MRI), and positron emission tomography (PET). Multiplanar multidetector computed tomography and multiparametric MRI with diffusion-weighted imaging are the main imaging modalities for renal cell carcinoma and urothelial carcinoma, and although multiparametric MRI is rapidly becoming the main imaging tool in the evaluation of prostate adenocarcinoma, biopsy is still required for diagnosis. Functional and molecular imaging using 18-fluorodeoxyglucose-PET and sodium fluoride-PET are essential for the diagnosis, and especially follow-up, of metastatic GU tumors. This review provides an overview of the latest advances in the imaging of these 3 major GU cancers.

AB - Medical imaging of the 3 most common genitourinary (GU) cancers—prostate adenocarcinoma, renal cell carcinoma, and urothelial carcinoma of the bladder—has evolved significantly during the last decades. The most commonly used imaging modalities for the diagnosis, staging, and follow-up of GU cancers are computed tomography, magnetic resonance imaging (MRI), and positron emission tomography (PET). Multiplanar multidetector computed tomography and multiparametric MRI with diffusion-weighted imaging are the main imaging modalities for renal cell carcinoma and urothelial carcinoma, and although multiparametric MRI is rapidly becoming the main imaging tool in the evaluation of prostate adenocarcinoma, biopsy is still required for diagnosis. Functional and molecular imaging using 18-fluorodeoxyglucose-PET and sodium fluoride-PET are essential for the diagnosis, and especially follow-up, of metastatic GU tumors. This review provides an overview of the latest advances in the imaging of these 3 major GU cancers.

KW - Bladder urothelial carcinoma

KW - CT

KW - MRI

KW - PET

KW - Prostate adenocarcinoma

KW - Renal cell carcinoma

UR - http://www.scopus.com/inward/record.url?scp=85019101787&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=85019101787&partnerID=8YFLogxK

U2 - 10.1016/j.urolonc.2017.04.014

DO - 10.1016/j.urolonc.2017.04.014

M3 - Review article

C2 - 28506596

AN - SCOPUS:85019101787

SN - 1078-1439

VL - 35

SP - 473

EP - 491

JO - Urologic Oncology: Seminars and Original Investigations

JF - Urologic Oncology: Seminars and Original Investigations

IS - 7

ER -

Advances in medical imaging for the diagnosis and management of common genitourinary cancers

Abstract

Keywords

ASJC Scopus subject areas

UN SDGs

Access to Document

Other files and links

Fingerprint

Cite this